IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Recent Advances in Anti-Infective Drug Discovery

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

1.07

h-Index

2023-2024

 38

Rank

2023-2024

 19792

SJR

2023-2024

 0.203

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Recent Advances in Anti-Infective Drug Discovery
Abbreviation Recent Adv. Anti-Infect. Drug Discov.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (medical) (Q3); Drug Discovery (Q4); Infectious Diseases (Q4)
h-index 38
Overall Rank/Ranking 19792
SCImago Journal Rank (SJR) 0.203
Impact Score 1.07
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 27724352, 27724344
Best Quartile Q3
Coverage History 2021-2023




About Recent Advances in Anti-Infective Drug Discovery


Recent Advances in Anti-Infective Drug Discovery is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q3); Drug Discovery (Q4); Infectious Diseases (Q4). It is published by Bentham Science Publishers. The overall rank of Recent Advances in Anti-Infective Drug Discovery is 19792. According to SCImago Journal Rank (SJR), this journal is ranked 0.203. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 38. The best quartile for this journal is Q3.

The ISSN of Recent Advances in Anti-Infective Drug Discovery journal is 27724352, 27724344. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Recent Advances in Anti-Infective Drug Discovery is cited by a total of 58 articles during the last 3 years (Preceding 2023).


Recent Advances in Anti-Infective Drug Discovery Impact IF 2023-2024


The Impact IF 2023 of Recent Advances in Anti-Infective Drug Discovery is 1.07, which is computed in 2024 as per its definition. Recent Advances in Anti-Infective Drug Discovery IF is decreased by a factor of 0.23 and approximate percentage change is -17.69% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Recent Advances in Anti-Infective Drug Discovery Impact IF 2024 Prediction


Impact IF 2023 of Recent Advances in Anti-Infective Drug Discovery is 1.07. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Recent Advances in Anti-Infective Drug Discovery. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 1.07
2022 1.30
2021 1.40
2020 1.88
2019 0.97
2018 0.96
2017 1.26
2016 1.25
2015 2.15
2014 2.00

Recent Advances in Anti-Infective Drug Discovery h-index


  Table Setting

Recent Advances in Anti-Infective Drug Discovery has an h-index of 38. It means 38 articles of this journal have more than 38 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Recent Advances in Anti-Infective Drug Discovery ISSN


The ISSN of Recent Advances in Anti-Infective Drug Discovery is 27724352, 27724344. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Recent Advances in Anti-Infective Drug Discovery Rank and SCImago Journal Rank (SJR)


The overall rank of Recent Advances in Anti-Infective Drug Discovery is 19792. According to SCImago Journal Rank (SJR), this journal is ranked 0.203. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Recent Advances in Anti-Infective Drug Discovery by Year


Year SJR
2023/2024 Coming Soon
2023 0.203
2022 0.277
2021 0.301
2020
2019
2018
2017
2016
2015
2014

Ranking of Recent Advances in Anti-Infective Drug Discovery by Year


Year Ranking
2023/2024 Coming Soon
2023 19792
2022 15938
2021 14762
2020 34528
2019 32259
2018 33748
2017 34513
2016 33962
2015 33449
2014 32724

Recent Advances in Anti-Infective Drug Discovery Publisher


Table Setting

Recent Advances in Anti-Infective Drug Discovery is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2021-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Recent Advances in Anti-Infective Drug Discovery is Recent Adv. Anti-Infect. Drug Discov.. This abbreviation ('Recent Adv. Anti-Infect. Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Recent Advances in Anti-Infective Drug Discovery


If your research field is/are related to Pharmacology (medical) (Q3); Drug Discovery (Q4); Infectious Diseases (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Recent Advances in Anti-Infective Drug Discovery?

Recent Advances in Anti-Infective Drug Discovery latest impact IF is 1.07. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.15 (2015) and 0.96 (2018), respectively, in the last 10 years. Moreover, its average IS is 1.42 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Recent Advances in Anti-Infective Drug Discovery?

The Recent Advances in Anti-Infective Drug Discovery has an SJR (SCImago Journal Rank) of 0.203, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.301 in 2021 and the lowest being in 2020. Furthermore, the average SJR of the Recent Advances in Anti-Infective Drug Discovery over the previous 10-year period stands at 1.42.


What's the latest h-index of the Recent Advances in Anti-Infective Drug Discovery?

The latest h-index of the Recent Advances in Anti-Infective Drug Discovery is 38.


Who's the publisher of the Recent Advances in Anti-Infective Drug Discovery?

The Recent Advances in Anti-Infective Drug Discovery is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.


What's the current ranking of the Recent Advances in Anti-Infective Drug Discovery?

The Recent Advances in Anti-Infective Drug Discovery is currently ranked 19792 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 14762 in 2021 and its lowest position of 34528 in 2020.


What's the abbreviation or short name for the Recent Advances in Anti-Infective Drug Discovery?

The standard ISO4 abbreviation for the Recent Advances in Anti-Infective Drug Discovery is Recent Adv. Anti-Infect. Drug Discov..


Is the "Recent Advances in Anti-Infective Drug Discovery" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Recent Advances in Anti-Infective Drug Discovery is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Recent Advances in Anti-Infective Drug Discovery?

The Recent Advances in Anti-Infective Drug Discovery encompasses the following areas:

  • Pharmacology (medical)
  • Drug Discovery
  • Infectious Diseases

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Recent Advances in Anti-Infective Drug Discovery?

The Recent Advances in Anti-Infective Drug Discovery is assigned the following International Standard Serial Numbers (ISSN): 27724352, 27724344.


What's the best quartile of the Recent Advances in Anti-Infective Drug Discovery?

The best quartile for the Recent Advances in Anti-Infective Drug Discovery is Q3 (2023).


What's the coverage history of the Recent Advances in Anti-Infective Drug Discovery?

The Recent Advances in Anti-Infective Drug Discovery coverage history can be summarized as follows: 2021-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Field Archaeology journal 5619 Maney Publishing 45 1.64
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
Mathematical Modelling and Analysis journal 11193 Vilnius Gediminas Technical University 29 1.75
International Journal of Applied Linguistics journal 6241 Wiley-Blackwell Publishing Ltd 53 1.91
Syntax journal 3731 Wiley-Blackwell Publishing Ltd 33 0.93
Palaeontographica Abteilung B: Palaeophytologie book series 10391 E. Schweizerbart'sche Verlagsbuchhandlung 17 3.43
Asian Textile Journal trade journal 27997 G P S Kwatra 11 0.03
Oral Radiology journal 8912 Springer Japan 23 2.13
Acta Periodica Technologica journal 23723 University of Novi Sad, Faculty of Technology 21 0.31
American Journal of Immunology (discontinued) journal 19764 Science Publications 12 1.56

Check complete list




Year wise Impact Score (IS) of Recent Advances in Anti-Infective Drug Discovery

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 1.07
2022 1.30
2021 1.40
2020 1.88
2019 0.97
2018 0.96
2017 1.26
2016 1.25
2015 2.15
2014 2.00



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

Drugs
Adis International Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Protein and Cell
Oxford University Press | United Kingdom

Molecular Therapy
Cell Press | United States

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Journal of Medicinal Chemistry
American Chemical Society | United States

MedComm
John Wiley and Sons Inc. | United States

Molecular Therapy - Nucleic Acids
Cell Press | United States

See All

Top Journals/Conferences in Infectious Diseases

Immunity
Cell Press | United States

Nature Reviews Microbiology
Nature Publishing Group | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Lancet Infectious Diseases, The
Lancet Publishing Group | United Kingdom

Lancet Microbe, The
Elsevier Ltd | United Kingdom

Cellular and Molecular Immunology
Nature Publishing Group | United Kingdom

Drug Resistance Updates
Churchill Livingstone | United States

Lancet HIV,The
Elsevier Ltd | United Kingdom

Clinical Infectious Diseases
Oxford University Press | United Kingdom

Microbiology and Molecular Biology Reviews
American Society for Microbiology | United States

See All